Search
for
Sort by
Research 121–150 of 1000+
- Immune Cell-Targeting Biologics for Alopecia Areata: A New Paradigm in Precision Medicine
- Learning From Success and Failure: Biologics for Non-approved Skin Diseases
- COMPARATIVE EFFECTIVENESS OF REGENERATIVE BIOLOGICS IN AESTHETIC DERMATOLOGY: A SYSTEMATIC REVIEW WITH QUANTITATIVE SYNTHESIS EVALUATING EXOSOMES, PRP AND STEM-CELL-DERIVED THERAPIES ON SKIN AND HAIR
- COMPARATIVE EFFECTIVENESS OF REGENERATIVE BIOLOGICS IN AESTHETIC DERMATOLOGY: A SYSTEMATIC REVIEW WITH QUANTITATIVE SYNTHESIS EVALUATING EXOSOMES, PRP AND STEM-CELL-DERIVED THERAPIES ON SKIN AND HAIR
- Patient’s experience with subcutaneous and oral methotrexate for the treatment of rheumatoid arthritis
- Adverse Reactions to Biologic Medications Used in Allergy and Immunology Diseases
- P0881 Effectiveness and Safety of Tofacitinib in Biologic-Naïve Elderly Patients with Ulcerative Colitis
- Janus Kinase Inhibitors - A next generation treatment in Dermatology
- The emerging role of Janus kinase inhibitors in the treatment of autoimmune and inflammatory diseases
- Supplementary Material for: Case report - Hair shaft normalization and hair growth in SPINK5-syndromic epidermal differentiation disorder (Netherton syndrome) while on treatment with dupilumab: a novel therapeutic approach for Trichorrhexis invaginata
- Supplementary Material for: Case report - Hair shaft normalization and hair growth in SPINK5-syndromic epidermal differentiation disorder (Netherton syndrome) while on treatment with dupilumab: a novel therapeutic approach for Trichorrhexis invaginata
- Case report - Hair shaft normalization and hair growth in SPINK5-syndromic epidermal differentiation disorder (Netherton syndrome) while on treatment with dupilumab: a novel therapeutic approach for Trichorrhexis invaginata
- Cyclophosphamide: As bad as its reputation? Long-term single centre experience of cyclophosphamide side effects in the treatment of systemic autoimmune diseases
- Netherton Syndrome: A Case-Based Review of Diagnosis, Management, and Emerging Treatments.
- The Changing Landscape of Alopecia Areata: The Translational Landscape
- Alopecia Areata Associated with Dupilumab: National Database Study
- Repurposing FDA approved drugs for psoriasis indications through integrated molecular docking, one-SVM algorithm, and molecular dynamics simulation approaches
- Paradoxical Alopecia Areata Induced by IL‐17 and IL‐23 Inhibitors: A Systematic Review
- Systemic immunotherapies
- Efficacy and safety of systemic monotherapy in the management of generalized pustular psoriasis: A systematic review
- The imbalance between Type 17 T-cells and regulatory immune cell subsets in psoriasis vulgaris
- Approach to the Management of Patients With Hidradenitis Suppurativa: A Consensus Document
- Management of ‘refractory’ skin disease in patients with lupus erythematosus
- Management of Folliculitis Decalvans: A Systematic Review
- 5PSQ-056 Experience with tofacinitib and baricitinib in rheumatoid arthritis
- Alopecia secondary to anti-tumor necrosis factor-alpha therapy
- Management of folliculitis decalvans: The EADV task force on hair diseases position statement
- Swiss Practice Recommendations for the Management of Hidradenitis Suppurativa/Acne Inversa
- Designing the Future of Dermatology and Venereology
- Introduction to women's health therapeutics in dermatology: Special edition of the International Journal of Women's Dermatology